Literature DB >> 23085074

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia.

George Anderson, Michael Berk, Seetal Dodd, Karl Bechter, A Carlo Altamura, Bernardo Dell'osso, Shigenobu Kanba, Akira Monji, S Hossein Fatemi, Peter Buckley, Monojit Debnath, U N Das, Urs Meyer, Norbert Müller, Buranee Kanchanatawan, Michael Maes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23085074     DOI： 10.1016/j.pnpbp.2012.10.008

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  39 in total

1.  Prevention of schizophrenia--will a broader prevention agenda support this aim?

Authors:  Felice N Jacka; Michael Berk
Journal:  Schizophr Bull       Date:  2014-01-04       Impact factor: 9.306

2.  Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis.

Authors:  B S Fernandes; M Berk; C W Turck; J Steiner; C-A Gonçalves
Journal:  Mol Psychiatry       Date:  2013-12-17       Impact factor: 15.992

3.  Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy.

Authors:  Olakunle James Onaolapo; Olayemi Quyyom Ademakinwa; Temitayo Opeyemi Olalekan; Adejoke Yetunde Onaolapo
Journal:  Psychopharmacology (Berl)       Date:  2017-06-14       Impact factor: 4.530

4.  A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia.

Authors:  Vanessa F Gonçalves; Carolina Cappi; Christian M Hagen; Adolfo Sequeira; Marquis P Vawter; Andriy Derkach; Clement C Zai; Paula L Hedley; Jonas Bybjerg-Grauholm; Jennie G Pouget; Ari B Cuperfain; Patrick F Sullivan; Michael Christiansen; James L Kennedy; Lei Sun
Journal:  Biol Psychiatry       Date:  2018-03-15       Impact factor: 13.382

5.  Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.

Authors:  Tanya T Nguyen; Tomasz Kosciolek; Lisa T Eyler; Rob Knight; Dilip V Jeste
Journal:  J Psychiatr Res       Date:  2018-01-31       Impact factor: 4.791

6.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

7.  Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.

Authors:  Buranee Kanchanatawan; Solaphat Hemrungrojn; Supaksorn Thika; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-09-05       Impact factor: 5.590

8.  Dietary zinc supplement militates against ketamine-induced behaviours by age-dependent modulation of oxidative stress and acetylcholinesterase activity in mice.

Authors:  Olakunle J Onaolapo; Olayemi R Jegede; Omolade Adegoke; Marufat O Ayinde; Oloruntola M Akeredolu; Adejoke Y Onaolapo
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

9.  Demographic, clinical and social characteristics of forensic patients diagnosed with schizophrenia at the Free State Psychiatric Complex, Bloemfontein, South Africa.

Authors:  Nkomile Ntswaki Clourinah Setlaba; Nathaniel Lehlohonolo Mosotho; Gina Joubert
Journal:  Psychiatr Psychol Law       Date:  2020-03-13

Review 10.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.